Cochrane Abstracts
Selective estrogen receptor modulators (SERMs) for uterine leiomyomas
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Selective Estrogen Receptor Modulators (SERMs) for Uterine Leiomyomas." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437515/all/Selective_estrogen_receptor_modulators__SERMs__for_uterine_leiomyomas.
Selective estrogen receptor modulators (SERMs) for uterine leiomyomas. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437515/all/Selective_estrogen_receptor_modulators__SERMs__for_uterine_leiomyomas. Accessed January 21, 2026.
Selective estrogen receptor modulators (SERMs) for uterine leiomyomas. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437515/all/Selective_estrogen_receptor_modulators__SERMs__for_uterine_leiomyomas
Selective Estrogen Receptor Modulators (SERMs) for Uterine Leiomyomas [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437515/all/Selective_estrogen_receptor_modulators__SERMs__for_uterine_leiomyomas.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Selective estrogen receptor modulators (SERMs) for uterine leiomyomas
ID - 437515
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437515/all/Selective_estrogen_receptor_modulators__SERMs__for_uterine_leiomyomas
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
